GoodRx Holdings
GDRX
174 hedge funds and large institutions have $916M invested in GoodRx Holdings in 2022 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 36 closing their positions.
81% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 32
31% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 36
19.36% more ownership
Funds ownership: 167.61% → 186.97% (+19%)
4% more funds holding
Funds holding: 167 → 174 (+7)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1% less call options, than puts
Call options by funds: $10.5M | Put options by funds: $10.5M
67% less capital invested
Capital invested by funds: $2.79B → $916M (-$1.88B)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$31.8M |
| 2 |
Millennium Management
New York
|
+$13.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.1M |
| 4 |
Two Sigma Advisers
New York
|
+$12.6M |
| 5 |
D.E. Shaw & Co
New York
|
+$11.5M |
Top Sellers
| 1 |
DIG
Dragoneer Investment Group
San Francisco,
California
|
-$25.1M |
| 2 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
-$21.6M |
| 3 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$21.1M |
| 4 |
DM
Deerfield Management
New York
|
-$18.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$13.6M |
GDRX Hedge Fund Activity: Q2 2022 in Review
174 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2022, worth a combined $916M — down 67% from $2.79B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new GDRX positions and 36 closed out — a net gain of 11 holders — while 58 added to existing stakes and 32 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $31.8M. The largest seller was Dragoneer Investment Group, exiting entirely with an estimated $25.1M sold.
- 174 institutional investors held GoodRx Holdings (GDRX) as of Q2 2022, up from 167 in Q1 2022.
- Funds reported $916M of GoodRx Holdings stock for Q2 2022, down 67% quarter-over-quarter.
- 47 funds opened new GoodRx Holdings positions in Q2 2022 and 36 closed out, a net change of +11 holders.
- The largest GoodRx Holdings buyer in Q2 2022 was Renaissance Technologies, an estimated $31.8M added.
- The largest GoodRx Holdings seller in Q2 2022 was Dragoneer Investment Group, an estimated $25.1M sold.
Based on aggregated 13F filings for Q2 2022.